合成路线1
该中间体在本合成路线中的序号:
(XIX) Reaction of 3-(benzyloxy)propionic acid (I) with 4(R)-isopropyl-1,3-thiazolidine-2-thione (II) in the presence of 1-ethyl-3-[3-(dimethylamino)propyl]carbodiimide hydrochloride and DMAP gives 3-[3-(benzyloxy)propanoyl]-4(R)-isopropyl-1,3-thiazolidine-2-thione (III), which by treatment with tin(II) trifluoromethanesulfonate and excess acetaldehyde affords 3-[(2S,3R)-2-(benzyloxymethyl)-3-hydroxybutanoyl]-4(R)-isopropyl-1,3-thiazolidine-2-thione (IV). Protection of the hydroxy group of (IV) with tert-butyldimethylsilyl chloride in the presence of imidazole yields 3-[(2S,3R)-2-(benzyloxymethyl)-3-(tert-butyldimethylsilyloxy)butanoyl]-4(R)-isopropyl-1,3-thiazolidine-2-thione (V), which is treated with p-anisidine to afford (2S,3R)-2-(benzyloxymethyl)-3-(tert-butyldimethylsilyloxy)-N-(4-methoxyphenyl)butylamide (VI). Deprotection of (VI) by hydrogenation with Pd/C in methanol-acetic acid gives (2S,3R)-3-(tert-butyldimethylsilyloxy)-2-(hydroxymethyl)-N-(4-methoxyphenyl)butylamide (VII), which is mesylated with methanesulfonyl chloride in the presence of triethylamine to yield (2S,3R)-3-(tert-butyldimethylsilyloxy)-2-[(methanesulfonyloxy)methyl]-N-(4-methoxyphenyl)butylamide (VIII). Cyclization of (VIII) with sodium hydride in CH2Cl2-DMF affords 3(S)-[1(R)-(tert-butyldimethylsilyloxy)ethyl]-1-(4-methoxyphenyl) azetidin-2-one (IX), the nitrogen atom of which is deprotected with cerium ammonium nitrate (CAN) in a mixture of acetonitrile-water to yield 3(S)-[1(R)-(tert-butyldimethylsilyloxy)ethyl]azetidin-2-one (X). Compound (X) is stereoselectively converted to (3S,4R)-3-[1(R)-(tert-butyldimethylsilyloxy)ethyl]-4-acetoxyazetidin-2-one (XI) on treatment with peracetic acid and ruthenium(III) chloride. Compound (XI) and 4(S)-ethyl-3-propionyl-1,3-thiazolidine-2-thione (XII) give, on treatment with tin(II) trifluoromethanesulfonate, (3S,4R)-3-[1(R)-(tert-butyldimethysilyloxy)methyl]-4-[1(R)-[4(S)-ethyl-2-thioxo-1,3-thiazolidin-3-ylcarbonyl]ethyl]azetidin-2-one (XIII) as the major diastereoisomer. Reaction of (XIII) with imidazole in acetonitrile gives (3S,4R)-3-[1(R)-(tert-butyldimethylsilyloxy)ethyl]-4-[1(R)-(imidazol-1-ylcarbonyl)ethyl]azetidin-2-one (XIV), which is treated with Mg(O2CH2CO2PNB)2 in acetonitrile to yield (3S,4R)-3-[1(R)-(tert-butyldimethylsilyloxy)ethyl]-4-[1(R)-methyl-3-(p-nitrobenzyloxycarbonyl)-2-oxopropyl]azetidin-2-one (XV). Compound (XV) is deprotected with hydrochloric acid in methanol to give (3S,4R)-3-[1(R)-hydroxyethyl]-4-[1(R)-methyl-3-(p-nitrobenzyloxycarbonyl)-2-oxopropyl]azetidin-2-one (XVI), which on diazotization with dodecylbenzenesulfonyl azide in acetonitrile yields (3S,4R)-4-[3-diazo-1(R)-methyl-3-(p-nitrobenzyloxycarbonyl)-2-oxopropyl]-3-[1(R)-hydroxyethyl]azetidin-2-one (XVII). Treatment of compound (XVII) with rhodium(II) octanoate in ethylacetate gives p-nitrobenzyl (1R,5R,6S)-6-[1(R)-hydroxyethyl]-1-methyl-2-oxocarbapenam-3-carboxylate (XVIII), which is reacted with diphenylchlorophosphate and diisopropylethylamine to afford p-nitrobenzyl (1R,5R,6S)-2-[(diphenylphosphono)oxy]-6-[1(R)-hydroxyethyl]-1-methylcarbapen-2-em-3-carboxylate (XIX).
【1】
Kumagai, T.; Matsunaga, H.; Machida, Y.; Nagase, Y.; Hikida, M.; Nagao, Y. (Lederle (Japan), Ltd.); (1R,5S,6S)-2-(Substd. thio)-6-[(R)-1-hydroxy-ethyl]-1-methyl-carbapenem-3-carboxylic-acid derivatives. AU 8814428; EP 0289801; JP 1989025779; US 4925836 . |
【2】
Abe, T.; Matsunaga, H.; Kumagai, T.; Nagase, Y. (Lederle (Japan), Ltd.); Method of preparation of carbapenem cpds. JP 1990088578 .
|
【3】
Rabasseda, X.; Prous, J.; Castaner, J.; Biapenem. Drugs Fut 1994, 19, 7, 631.
|
【4】
Hayashi, T.; Shimada, O.; Inoue, Y.; Nagao, Y.; Matsunaga, H.; Nagase, Y.; Kumagai, T.; Abe, T.; beta-Lactams. 3. Asymmetric total synthesis of new non-natural 1beta-methylcarbapenems exhibiting strong antimicrobial activities and stability against human renal dehydropeptidase-. J Org Chem 1992, 57, 15, 4243-9. |
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
13189 |
3-(Benzyloxy)propionic acid
|
|
C10H12O3 |
详情 |
详情
|
(II) |
13190 |
(4R)-4-Isopropyl-1,3-thiazolidine-2-thione
|
|
C6H11NS2 |
详情 |
详情
|
(III) |
13191 |
3-(Benzyloxy)-1-[(4R)-4-isopropyl-2-thioxo-1,3-thiazolidin-3-yl]-1-propanone
|
|
C16H21NO2S2 |
详情 |
详情
|
(IV) |
13192 |
(2S,3R)-2-[(Benzyloxy)methyl]-3-hydroxy-1-[(4R)-4-isopropyl-2-thioxo-1,3-thiazolidin-3-yl]-1-butanone
|
|
C18H25NO3S2 |
详情 |
详情
|
(V) |
13193 |
(2S,3R)-2-[(Benzyloxy)methyl]-3-[[tert-butyl(dimethyl)silyl]oxy]-1-[(4R)-4-isopropyl-2-thioxo-1,3-thiazolidin-3-yl]-1-butanone
|
|
C24H39NO3S2Si |
详情 |
详情
|
(VI) |
13194 |
(2S,3R)-2-[(Benzyloxy)methyl]-3-[[tert-butyl(dimethyl)silyl]oxy]-N-(4-methoxyphenyl)butanamide
|
|
C25H37NO4Si |
详情 |
详情
|
(VII) |
13195 |
(2S,3R)-3-[[tert-Butyl(dimethyl)silyl]oxy]-2-(hydroxymethyl)-N-(4-methoxyphenyl)butanamide
|
|
C18H31NO4Si |
详情 |
详情
|
(VIII) |
13196 |
(2S,3R)-3-[[tert-butyl(dimethyl)silyl]oxy]-2-[(4-methoxyanilino)carbonyl]butyl methanesulfonate
|
|
C19H33NO6SSi |
详情 |
详情
|
(IX) |
13197 |
(3S)-3-((1R)-1-[[tert-Butyl(dimethyl)silyl]oxy]ethyl)-1-(4-methoxyphenyl)-2-azetidinone
|
|
C18H29NO3Si |
详情 |
详情
|
(X) |
13198 |
(3S)-3-((1R)-1-[[tert-Butyl(dimethyl)silyl]oxy]ethyl)-2-azetidinone
|
|
C11H23NO2Si |
详情 |
详情
|
(XI) |
11687 |
(2R,3R)-3-((1R)-1-[[tert-butyl(dimethyl)silyl]oxy]ethyl)-4-oxoazetanyl acetate
|
|
C13H25NO4Si |
详情 |
详情
|
(XII) |
13200 |
1-[(4S)-4-Ethyl-2-thioxo-1,3-thiazolidin-3-yl]-1-propanone
|
|
C8H13NOS2 |
详情 |
详情
|
(XIII) |
13201 |
(3S,4S)-3-((1R)-1-[[tert-Butyl(dimethyl)silyl]oxy]ethyl)-4-[(1R)-2-[(4S)-4-ethyl-2-thioxo-1,3-thiazolidin-3-yl]-1-methyl-2-oxoethyl]-2-azetidinone
|
|
C19H34N2O3S2Si |
详情 |
详情
|
(XIV) |
13202 |
(3S,4S)-3-((1R)-1-[[tert-Butyl(dimethyl)silyl]oxy]ethyl)-4-[(1R)-2-(1H-imidazol-1-yl)-1-methyl-2-oxoethyl]-2-azetidinone
|
|
C17H29N3O3Si |
详情 |
详情
|
(XV) |
33040 |
4-nitrobenzyl (4R)-4-[(2R,3S)-3-((1R)-1-[[tert-butyl(dimethyl)silyl]oxy]ethyl)-4-oxoazetidinyl]-3-oxopentanoate
|
|
C23H34N2O7Si |
详情 |
详情
|
(XVI) |
22573 |
4-nitrobenzyl 4-[(2R,3S)-3-[(1R)-1-hydroxyethyl]-4-oxoazetidinyl]-3-oxopentanoate
|
|
C17H20N2O7 |
详情 |
详情
|
(XVII) |
38749 |
4-nitrobenzyl (4R)-2-diazo-4-[(2R,3S)-3-[(1R)-1-hydroxyethyl]-4-oxoazetidinyl]-3-oxopentanoate
|
|
C17H18N4O7 |
详情 |
详情
|
(XVIII) |
37720 |
4-nitrobenzyl (4R,5R,6S)-6-[(1R)-1-hydroxyethyl]-4-methyl-3,7-dioxo-1-azabicyclo[3.2.0]heptane-2-carboxylate
|
|
C17H18N2O7 |
详情 |
详情
|
(XIX) |
13224 |
4-nitrobenzyl (4R,5R,6S)-3-[(diphenoxyphosphoryl)oxy]-6-[(1R)-1-hydroxyethyl]-4-methyl-7-oxo-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylate
|
90776-59-3 |
C29H27N2O10P |
详情 | 详情
|
合成路线2
该中间体在本合成路线中的序号:
(XIX) Compound (XIX) reacts with 4-mercapto-N,N-bis(p-nitrobenzyloxycarbonyl)pyrazolidine (XX) in the presence of diisopropylethylamine to give p-nitrobenzyl (1R,5R,6S)-2-[[N,N-bis(p-nitrobenzyloxycarbonyl)pyrazolidin-4-yl]thio]-6-[1(R)-hydroxyethyl]-1-methylcarbapen-2-em-3-carboxylate (XXIII).
Compound (XXIII) is reduced with H2 over Pd/C to give (1R,5R,6S)-2-[[N,N-bis(p-nitrobenzyloxycarbonyl)pyrazolidin-4-yl]thio]-6-[1(R)-hydroxyethyl]-1-methylcarbapen-2-em-3-carboxylate (XXIV), which is finally reacted with ethylformimidate hydrochloride (XXV).
Compound (XX) is obtained from epichlorohydrin (XXI) by treatment with hydrazine monohydrate followed by reaction with p-nitrobenzyloxycarbonyl chloride to give 4-hydroxy-N,N-bis(p-nitrobenzyloxycarbonyl)pyrazolidine (XXII), which is subsequently treated with methanesulfonyl chloride and triethylamine in dichloromethane, potassium acetate in acetone and sodium methoxide in methanol-THF. Compound (XX) can also be obtained from hydrazine hydrate using a longer alternative procedure.
【1】
Kumagai, T.; Matsunaga, H.; Machida, Y.; Nagase, Y.; Hikida, M.; Nagao, Y. (Lederle (Japan), Ltd.); (1R,5S,6S)-2-(Substd. thio)-6-[(R)-1-hydroxy-ethyl]-1-methyl-carbapenem-3-carboxylic-acid derivatives. AU 8814428; EP 0289801; JP 1989025779; US 4925836 . |
【2】
Abe, T.; Matsunaga, H.; Kumagai, T.; Nagase, Y. (Lederle (Japan), Ltd.); Method of preparation of carbapenem cpds. JP 1990088578 .
|
【3】
Hayashi, T.; Shimada, O.; Inoue, Y.; Nagao, Y.; Matsunaga, H.; Nagase, Y.; Kumagai, T.; Abe, T.; beta-Lactams. 3. Asymmetric total synthesis of new non-natural 1beta-methylcarbapenems exhibiting strong antimicrobial activities and stability against human renal dehydropeptidase-. J Org Chem 1992, 57, 15, 4243-9. |
【4】
Rabasseda, X.; Prous, J.; Castaner, J.; Biapenem. Drugs Fut 1994, 19, 7, 631.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(XIX) |
13224 |
4-nitrobenzyl (4R,5R,6S)-3-[(diphenoxyphosphoryl)oxy]-6-[(1R)-1-hydroxyethyl]-4-methyl-7-oxo-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylate
|
90776-59-3 |
C29H27N2O10P |
详情 | 详情
|
(XX) |
13208 |
bis(4-nitrobenzyl) 4-sulfanyl-1,2-pyrazolidinedicarboxylate
|
|
C19H18N4O8S |
详情 |
详情
|
(XXI) |
10146 |
Epichlorohydrin; 2-(Chloromethyl)oxirane
|
106-89-8 |
C3H5ClO |
详情 | 详情
|
(XXII) |
13210 |
bis(4-nitrobenzyl) 4-hydroxy-1,2-pyrazolidinedicarboxylate
|
|
C19H18N4O9 |
详情 |
详情
|
(XXIII) |
13211 |
bis(4-nitrobenzyl) 4-([(4R,5S,6S)-6-[(1R)-1-hydroxyethyl]-4-methyl-2-[2-(4-nitrophenyl)acetyl]-7-oxo-1-azabicyclo[3.2.0]hept-2-en-3-yl]sulfanyl)-1,2-pyrazolidinedicarboxylate
|
|
C36H34N6O13S |
详情 |
详情
|
(XXIV) |
13212 |
(4R,5S,6S)-3-[(1,2-bis[[(4-Nitrobenzyl)oxy]carbonyl]-4-pyrazolidinyl)sulfanyl]-6-[(1R)-1-hydroxyethyl]-4-methyl-7-oxo-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid
|
|
C29H29N5O12S |
详情 |
详情
|
(XXV) |
13213 |
ethyl iminoformate
|
|
C3H7NO |
详情 |
详情
|
合成路线3
该中间体在本合成路线中的序号:
(XII) 2) The acylation of hydrazine (I) with di-tert-butyl dicarbonate (II) gives 1,2-di(tert-butyloxycarbonyl)hydrazine (III), which is cyclized with 1,3-dibromo-2-(tert-butyldimethylsilyloxy)propane (IV) by means of NaH in DMF yielding the pyrazolidine (V). The desilylation of (V) with tetrabutylammonium fluoride in THF affords 1,2-di(tert-butoxycarbonyl)-4-hydroxypyrazolidine (VI). Acylation of (VI) with methanesulfonyl chloride in dichloromethane gives the corresponding mesylate (VII), which is condensed with 4-methoxybenzyl mercaptane (VIII) by means of butyllithium in hexane to yield the benzyl ether (IX). The cyclization of (IX) with methyl formimidate hydrochloride in methanol-water affords 6-(4-methoxybenzylthio)-6,7-dihydro-5H-pyrazolo[1,2-a][1,2,4]triazolium chloride (X), which is deprotected with trifluoroacetic acid giving 6-mercapto-6,7-dihydro-5H-pyrazolo[1,2-a][1,2,4]triazolium chloride (XI). Finally, this compound is condensed with (1R,5R,6S)-2-(diphenylphosphonooxy)-6-[1(R)-hydroxyethyl]-1-methyl-1-carba-2-penem-3-carboxylic acid 4-nitrobenzyl ester (XII) by means of diisopropylethylamine in DMF followed by hydrogenolysis with H2 over Pd/C in butanol-EtOAc-potassium phosphate buffer.
【1】
Ratcliffe, R.W.; Wildonger, K.J.; Heteroaryliumthio substituted carbapenem derivatives: Synthesis and in vitro activity of 1beta-methyl-2-(dihydropyrrolotriazoliumthio)carbapenems. J Antibiot 1993, 46, 12, 1866-82.
|
【2】
Rabasseda, X.; Prous, J.; Castaner, J.; Biapenem. Drugs Fut 1994, 19, 7, 631.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(II) |
13214 |
Di-tert-butyldicarbonate; Dicarbonic acid bis(1,1-dimethylethyl) ester; dicarbonic acid di-tert-butyl ester
pyrocarbonic acid di-tert-butyl ester; bis(1,1-dimethylethyl) dicarbonate
di-tert-butyl pyrocarbonate
|
24424-99-5 |
C10H18O5 |
详情 | 详情
|
(III) |
13215 |
di(tert-butyl) 1,2-hydrazinedicarboxylate; Di-tert-butyl hydrazodicarboxylate
|
16466-61-8 |
C10H20N2O4 |
详情 | 详情
|
(IV) |
13216 |
[2-Bromo-1-(bromomethyl)ethoxy](tert-butyl)dimethylsilane; 2-Bromo-1-(bromomethyl)ethyl tert-butyl(dimethyl)silyl ether
|
|
C9H20Br2OSi |
详情 |
详情
|
(V) |
13217 |
di(tert-butyl) 4-[[tert-butyl(dimethyl)silyl]oxy]-1,2-pyrazolidinedicarboxylate
|
|
C19H38N2O5Si |
详情 |
详情
|
(VI) |
13218 |
di(tert-butyl) 4-hydroxy-1,2-pyrazolidinedicarboxylate
|
|
C13H24N2O5 |
详情 |
详情
|
(VII) |
13219 |
di(tert-butyl) 4-[(methylsulfonyl)oxy]-1,2-pyrazolidinedicarboxylate
|
|
C14H26N2O7S |
详情 |
详情
|
(VIII) |
13220 |
4-Methoxybenzylhydrosulfide; (4-Methoxyphenyl)methanethiol; 4-Methoxy-alpha-toluenethiol
|
6258-60-2 |
C8H10OS |
详情 | 详情
|
(IX) |
13221 |
di(tert-butyl) 4-[(4-methoxybenzyl)sulfanyl]-1,2-pyrazolidinedicarboxylate
|
|
C21H32N2O5S |
详情 |
详情
|
(X) |
13222 |
6-[(4-Methoxybenzyl)sulfanyl]-5H,6H,7H-pyrazolo[1,2-a][1,2,4]triazol-4-ium chloride
|
|
C13H16ClN3OS |
详情 |
详情
|
(XI) |
13223 |
6-Sulfanyl-5H,6H,7H-pyrazolo[1,2-a][1,2,4]triazol-4-ium chloride
|
153851-71-9 |
C5H8ClN3S |
详情 | 详情
|
(XII) |
13224 |
4-nitrobenzyl (4R,5R,6S)-3-[(diphenoxyphosphoryl)oxy]-6-[(1R)-1-hydroxyethyl]-4-methyl-7-oxo-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylate
|
90776-59-3 |
C29H27N2O10P |
详情 | 详情
|
合成路线4
该中间体在本合成路线中的序号:
(X) A new synthesis of BO-2727 has been described:
The condensation of (2S,4R)-1-(tert-butoxycarbonyl)-4-(tert-butyldimethylsilyloxy)pyrrolidine-2-carbaldehyde (I) with ethyl acetate (II) by means of butyllithium and hexa-methyldisylazane (HMSA) in THF gives 3-[1-(tert-butoxycarbonyl)-4(R)-(tert-butyldimethylsilyloxy) pyrrolidin-2(S)-yl]-3-hydroxypropionic acid ethyl ester (III), which was submitted to column chromatography over silicagel yielding the pure 3(R)-hydroxypropionic acid (IV). The reduction of (IV) with NaBH4 in THF afforded the expected diol (V), which was treated with tosyl chloride and triethylamine to give the monotosylate (VI). The reaction of (VI) first with methylamine in methanol, and then with p-nitrobenzyloxycarbonyl chloride (PNZ-Cl) in the same solvent yielded (2S,4R)-2-[1(R)-hydroxy-3-[N-methyl-N-(p-nitrobenzyloxycarbonyl)amino]propyl] pyrrolidin-4-ol (VII). The reaction of (VII) first with SOCl2 and then with potassium thioacetate afforded the 4(R)-acetylsulfanyl derivative (VIII), which was hydrolyzed with NaOH in methanol/water to the corresponding thiol (IX). The condensation of (IX) with the carbapenem intermediate (X) by means of diisopropylethylamine (DIEA) in acetonitrile gave the precursor (protected) of BO-2727 (XI), which was finally deprotected by hydrogenation with H2 over Pd/C in THF/ethanol/pH-7 buffer.
【1】
Ohtake, N.; Okamoto, O.; Mitomo, R.; Kato, Y.; Yamamoto, K.; Haga, Y.; Fukatsu, H.; Nakagawa, S.; 1ß-Methyl-2-(5-substituted pyrrolidin-3-ylthio)carbapenems; 3. Synthesis and antibacterial activity of BO-2727 and its related compounds. J Antibiot 1997, 50, 7, 598. |
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
17490 |
tert-butyl (2S,4R)-4-[[tert-butyl(dimethyl)silyl]oxy]-2-formyl-1-pyrrolidinecarboxylate
|
|
C16H31NO4Si |
详情 |
详情
|
(II) |
17491 |
ethyl acetate
|
141-78-6 |
C4H8O2 |
详情 | 详情
|
(III) |
17492 |
tert-butyl (2S,4R)-4-[[tert-butyl(dimethyl)silyl]oxy]-2-(3-ethoxy-1-hydroxy-3-oxopropyl)-1-pyrrolidinecarboxylate
|
|
C20H39NO6Si |
详情 |
详情
|
(IV) |
17493 |
tert-butyl (2S,4R)-4-[[tert-butyl(dimethyl)silyl]oxy]-2-[(1R)-3-ethoxy-1-hydroxy-3-oxopropyl]-1-pyrrolidinecarboxylate
|
|
C20H39NO6Si |
详情 |
详情
|
(V) |
17494 |
tert-butyl (2S,4R)-4-[[tert-butyl(dimethyl)silyl]oxy]-2-[(1R)-1,3-dihydroxypropyl]-1-pyrrolidinecarboxylate
|
|
C18H37NO5Si |
详情 |
详情
|
(VI) |
17495 |
tert-butyl (2S,4R)-4-[[tert-butyl(dimethyl)silyl]oxy]-2-((1R)-1-hydroxy-3-[[(4-methylphenyl)sulfonyl]oxy]propyl)-1-pyrrolidinecarboxylate
|
|
C25H43NO7SSi |
详情 |
详情
|
(VII) |
16203 |
4-nitrobenzyl (2S,4R)-4-hydroxy-2-[(1R)-1-hydroxy-3-(methyl[[(4-nitrobenzyl)oxy]carbonyl]amino)propyl]-1-pyrrolidinecarboxylate
|
|
C24H28N4O10 |
详情 |
详情
|
(VIII) |
16204 |
4-nitrobenzyl (2S,4S)-4-(acetylsulfanyl)-2-[(1R)-1-hydroxy-3-(methyl[[(4-nitrobenzyl)oxy]carbonyl]amino)propyl]-1-pyrrolidinecarboxylate
|
|
C26H30N4O10S |
详情 |
详情
|
(IX) |
16205 |
4-nitrobenzyl (2S,4S)-2-[(1R)-1-hydroxy-3-(methyl[[(4-nitrobenzyl)oxy]carbonyl]amino)propyl]-4-sulfanyl-1-pyrrolidinecarboxylate
|
|
C24H28N4O9S |
详情 |
详情
|
(X) |
13224 |
4-nitrobenzyl (4R,5R,6S)-3-[(diphenoxyphosphoryl)oxy]-6-[(1R)-1-hydroxyethyl]-4-methyl-7-oxo-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylate
|
90776-59-3 |
C29H27N2O10P |
详情 | 详情
|
(XI) |
16207 |
4-nitrobenzyl (2S,4S)-4-([(4R,5S,6S)-6-[(1R)-1-hydroxyethyl]-4-methyl-2-[2-(4-nitrophenyl)acetyl]-7-oxo-1-azabicyclo[3.2.0]hept-2-en-3-yl]sulfanyl)-2-[(1R)-1-hydroxy-3-(methyl[[(4-nitrobenzyl)oxy]carbonyl]amino)propyl]-1-pyrrolidinecarboxylate
|
|
C41H44N6O14S |
详情 |
详情
|
合成路线5
该中间体在本合成路线中的序号:
(XVI) Condensation of (phosphoryloxy)carbapenem (XVI) with 3-mercapto-1-(1,3-thiazolin-2-yl)azetidine (XI) gave thioether (XVII). The p-nitrobenzyl ester group of (XVII) was then deprotected with Zn powder to afford the target carboxylic acid.
【1】
Satoh, C.; Mihira, A.; Yamamoto, S.; Hayashi, K.; Kitamura, M.; Tamai, S.; Abe, T.; Kumagai, T.; Hikida, M.; L-084, a new oral carbapenem: Synthesis and structure-activity relationships of C2-substituted 1beta-methylcarbapenems. 38th Intersci Conf Antimicrob Agents Chemother (Sept 24 1998, San Diego) 1998, Abst F-64. |
【2】
Abe, T.; Isoda, T.; Sato, C.; Mihira, A.; Tamai, S.; Kumagai, T. (Lederle (Japan), Ltd.); 2-(1-(1,3-Thiazolin-2-yl)azetidin-3-yl)thio-carbapenem derivs.. EP 0632039; EP 0717042; JP 1996053453; US 5534510; US 5659043; US 5783703 .
|
【3】
Abe, T.; Kumagai, T. (Lederle (Japan), Ltd.); Carbapenem-3-carboxylic acid ester derivs.. EP 0808315; JP 1999504039; US 5886172; WO 9721712 .
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(XI) |
31404 |
1-(4,5-dihydro-1,3-thiazol-2-yl)-3-azetidinylhydrosulfide; 1-(4,5-dihydro-1,3-thiazol-2-yl)-3-azetidinethiol
|
179337-57-6 |
C6H10N2S2 |
详情 | 详情
|
(XVI) |
13224 |
4-nitrobenzyl (4R,5R,6S)-3-[(diphenoxyphosphoryl)oxy]-6-[(1R)-1-hydroxyethyl]-4-methyl-7-oxo-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylate
|
90776-59-3 |
C29H27N2O10P |
详情 | 详情
|
(XVII) |
31408 |
4-nitrobenzyl (4R,5S,6S)-3-[[1-(4,5-dihydro-1,3-thiazol-2-yl)-3-azetidinyl]sulfanyl]-6-[(1R)-1-hydroxyethyl]-4-methyl-7-oxo-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylate
|
|
C23H26N4O6S2 |
详情 |
详情
|
合成路线6
该中间体在本合成路线中的序号:
(I) The condensation of the enolphosphate (I) (1) and the thiol (II) in the presence of diisopropylethylamine gives the protected compound (III), which is deprotected by hydrogenolysis with H2 over Pd(OH)2 on carbon, purified by reverse-phase silica gel chromatography and treated with HCl to afford ER-35786 (2), as shown in Scheme 22662001a.
【1】
Kaneda, S.; Hayasi, K.; Kumagai, T.; Crystalline 1-methyl-2-diphenylphosphoryloxy-carbapenem compounds. JP 92330085 .
|
【2】
Sato, N.; Ohba, F.; ER-35786. Drugs Fut 1996, 21, 4, 361.
|
【3】
Sato, N.; Sasho, M.; Kamada, A.; Suzuki, T.; Ashizawa, K.; Sugiyama, I.; ER-35786, a new antipseudomonal carbapenem: I. Synthesis and structure-activity relations of 2-substituted 1beta-methyl carbapenems. 35th Intersci Conf Antimicrob Agents Chemother (Sept 17-20, San Francisco) 1995, Abst F151. |
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
13224 |
4-nitrobenzyl (4R,5R,6S)-3-[(diphenoxyphosphoryl)oxy]-6-[(1R)-1-hydroxyethyl]-4-methyl-7-oxo-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylate
|
90776-59-3 |
C29H27N2O10P |
详情 | 详情
|
(II) |
17113 |
(R)-[(2S,4S)-1-methyl-4-sulfanyltetrahydro-1H-pyrrol-2-yl][(3R)-1-methyltetrahydro-1H-pyrrol-3-yl]methanol
|
|
C11H22N2OS |
详情 |
详情
|
(III) |
17114 |
methyl (4R,5S,6S)-6-[(1R)-1-hydroxyethyl]-3-[((3S,5S)-5-[(R)-hydroxy[(3R)-1-methylpyrrolidinyl]methyl]-1-methylpyrrolidinyl)sulfanyl]-4-methyl-7-oxo-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylate
|
|
C22H35N3O5S |
详情 |
详情
|
合成路线7
该中间体在本合成路线中的序号:
(VI) 1) The mesylation of 4(S)-hydroxypyrrolidin-2-one (I) with mesyl chloride and triethylamine in pyridine gives the corresponding ester (II), which is treated with potassium thioacetate (III) in refluxing acetonitrile yielding 4(R)-(acetylsulfanyl)pyrrolidin-2-one (IV). The hydrolysis of (IV) with sodium methoxide in methanol followed by acidification with aqueous HCl affords 4(R)-sulfanylpyrrolidin-2-one (V), which is condensed with (1R,5S,6S)-2-(diphenoxyphosphoryloxy)-6-[1(R)-hydroxyethyl]-1-methyl-1-carba-2-penem-3-carboxylic acid p-nitrobenzyl ester (VI) by means of ethyldiisopropylamine in acetonitrile to give (1R,5S,6S)-6-[1(R)-hydroxyethyl]-1-methyl-2-[5-oxopyrrolidin-3(R)-ylsulfanyl]-1-carba-2-penem-3-carboxylic acid p-nitrobenzyl ester (VII). The hydrogenolysis of (VII) with H2 over Pd/C in THF/aqueous phosphate buffer yields the sodium salt (VIII), which is finally esterified with pivaloyloxymethyl iodide (IX) in dimethylacetamide.
【1】
Yasuda, H.; Kuwahara, S.; Kawamoto, I.; Miyauchi, M.; Endo, R.; Hisaoka, M.; CS-834, a new oral carbapenem: I. Structure-activity relationships of 2-substituted 1beta-methylcarbapenems. 36th Intersci Conf Antimicrob Agents Chemother (Sept 15-18, New Orleans) 1996, Abst F105. |
【2】
Endo, R.; Yasuda, H.; Kawamoto, I.; Hisaoka, M.; Miyauchi, M.; Synthesis and structure-activity relationships of a novel oral carbapenem, CS-834. J Antibiot 1997, 50, 5, 429-39.
|
【3】
Graul, A.; Castañer, R.M.; Castañer, J.; Leeson, P.; CS-834. Drugs Fut 1998, 23, 3, 261. |
【4】
Kawamoto, I.; Tanaka, T.; Endo, R.; Miyauchi, M.; Iwata, M. (Sankyo Co., Ltd.); 2-(Heterocyclylthio)carbapenem derivs. their preparation and their use as antibiotics. AU 8932386; EP 0337637; EP 0597821; JP 1990028180; JP 1990049783; US 5104867; US 5242914 . |
【5】
Kawamoto, I.; Miyauchi, M.; Endo, R. (Sankyo Co., Ltd.); Crystalline carbapenem deriv. EP 0599512; JP 1995165759 .
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
17188 |
(S)-4-hydroxy-2-pyrrolidone; (4S)-4-hydroxytetrahydro-2H-pyrrol-2-one; (S)-4-hydroxypyrrolidone
|
68108-18-9 |
C4H7NO2 |
详情 | 详情
|
(II) |
17189 |
(3S)-5-oxotetrahydro-1H-pyrrol-3-yl methanesulfonate
|
|
C5H9NO4S |
详情 |
详情
|
(III) |
17190 |
potassium ethanethioate
|
10387-40-3 |
C2H3KOS |
详情 | 详情
|
(IV) |
17191 |
S-[(3R)-5-oxotetrahydro-1H-pyrrol-3-yl] ethanethioate
|
|
C6H9NO2S |
详情 |
详情
|
(V) |
17192 |
(4R)-4-sulfanyltetrahydro-2H-pyrrol-2-one
|
157429-42-0 |
C4H7NOS |
详情 | 详情
|
(VI) |
13224 |
4-nitrobenzyl (4R,5R,6S)-3-[(diphenoxyphosphoryl)oxy]-6-[(1R)-1-hydroxyethyl]-4-methyl-7-oxo-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylate
|
90776-59-3 |
C29H27N2O10P |
详情 | 详情
|
(VII) |
17194 |
4-nitrobenzyl (4R,5S,6S)-6-[(1R)-1-hydroxyethyl]-4-methyl-7-oxo-3-[[(3R)-5-oxotetrahydro-1H-pyrrol-3-yl]sulfanyl]-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylate
|
|
C21H23N3O7S |
详情 |
详情
|
(VIII) |
17195 |
sodium (4R,5S,6S)-6-[(1R)-1-hydroxyethyl]-4-methyl-7-oxo-3-[[(3R)-5-oxopyrrolidinyl]sulfanyl]-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylate
|
|
C14H17N2NaO5S |
详情 |
详情
|
(IX) |
11159 |
iodomethyl pivalate
|
|
C6H11IO2 |
详情 |
详情
|
合成路线8
该中间体在本合成路线中的序号:
(V) Coupling of thioacetylproline derivative (I) with p-nitrobenzyl ester of ciprofloxacin (II) in the presence of dicyclohexylcarbodiimide (DCC) and 4-dimethylaminopyridine (DMAP) provided amide (III). Treatment with pyrrolidine in acetonitrile gave thiol (IV), which was subsequently alkylated with the carbapenem phosphate (V) in the presence of diisopropylethylamine to give thioether (VI). Then, hydrogenolytical removal of p-nitrobenzyl protecting groups in the presence of Pd-C, followed by treatment with sodium 2-ethylhexanoate in acetone provided the target disodium salt.
【1】
Hershberger, P.M.; Switzer, A.G.; Yelm, K.E.; Coleman, M.C.; Devries, C.A.; Rourke, F.J.; Davis, B.W.; Kraft, W.G.; Twinem, T.L.; Koenigs, P.M.; Paule, S.M.; Siehnel, R.J.; Zoutendam, P.H.; Imbus, R.; Demuth, T.P. Jr.; Preparation and antimicrobial assessment of 2-thioether-linked quinolonyl-carbapenems. J Antibiot 1998, 51, 9, 857-871. |
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
18241 |
(2S,4S)-4-(acetylsulfanyl)-1-[[(4-nitrobenzyl)oxy]carbonyl]-2-pyrrolidinecarboxylic acid
|
|
C15H16N2O7S |
详情 |
详情
|
(II) |
18242 |
4-nitrobenzyl 1-cyclopropyl-6-fluoro-4-oxo-7-(1-piperazinyl)-1,4-dihydro-3-quinolinecarboxylate
|
|
C24H23FN4O5 |
详情 |
详情
|
(III) |
18243 |
4-nitrobenzyl 7-[4-[((2S,4S)-4-(acetylsulfanyl)-1-[[(4-nitrobenzyl)oxy]carbonyl]pyrrolidinyl)carbonyl]-1-piperazinyl]-1-cyclopropyl-6-fluoro-4-oxo-1,4-dihydro-3-quinolinecarboxylate
|
|
C39H37FN6O11S |
详情 |
详情
|
(IV) |
18244 |
4-nitrobenzyl 1-cyclopropyl-6-fluoro-7-[4-[((2S,4S)-1-[[(4-nitrobenzyl)oxy]carbonyl]-4-sulfanylpyrrolidinyl)carbonyl]-1-piperazinyl]-4-oxo-1,4-dihydro-3-quinolinecarboxylate
|
|
C37H35FN6O10S |
详情 |
详情
|
(V) |
13224 |
4-nitrobenzyl (4R,5R,6S)-3-[(diphenoxyphosphoryl)oxy]-6-[(1R)-1-hydroxyethyl]-4-methyl-7-oxo-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylate
|
90776-59-3 |
C29H27N2O10P |
详情 | 详情
|
(VI) |
18246 |
4-nitrobenzyl 1-cyclopropyl-6-fluoro-7-[4-[((2S,4S)-4-[((4R,5S,6S)-6-[(1R)-1-hydroxyethyl]-4-methyl-2-[[(4-nitrobenzyl)oxy]carbonyl]-7-oxo-1-azabicyclo[3.2.0]hept-2-en-3-yl)sulfanyl]-1-[[(4-nitrobenzyl)oxy]carbonyl]pyrrolidinyl)carbonyl]-1-piperazinyl]-4-oxo-1,4-dihydro-3-quinolinecarboxylate |
|
C54H51FN8O16S |
详情 |
详情
|
合成路线9
该中间体在本合成路线中的序号:
(VIII) Azetidineacetic acid derivative (I) was activated with 1,1'-carbonyldiimidazole and then condensed with p-nitrobenzyl malonate magnesium salt (II) to afford ketoester (III). Desilylation of (III) with methanolic HCl then gave alcohol (IV). Dodecylbenzenesulfonyl azide (VI) was prepared by treatment of sulfonyl chloride (V) with NaN3. Reaction of (IV) with sulfonyl azide (VI) provided diazo ester (VII). Ring closure of (VII) in the presence of rhodium diacetate in hot cyclohexane, followed by condensation with diphenylphosphoric chloride furnished carbapenem phosphate (VIII).
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
30029 |
(2R)-2-[(2S,3S)-3-((1R)-1-[[tert-butyl(dimethyl)silyl]oxy]ethyl)-4-oxoazetidinyl]propionic acid
|
|
C14H27NO4Si |
详情 |
详情
|
(II) |
33039 |
magnesium 2-(4-nitrobenzyl)malonate
|
|
C10H7MgNO6 |
详情 |
详情
|
(III) |
33040 |
4-nitrobenzyl (4R)-4-[(2R,3S)-3-((1R)-1-[[tert-butyl(dimethyl)silyl]oxy]ethyl)-4-oxoazetidinyl]-3-oxopentanoate
|
|
C23H34N2O7Si |
详情 |
详情
|
(IV) |
22573 |
4-nitrobenzyl 4-[(2R,3S)-3-[(1R)-1-hydroxyethyl]-4-oxoazetidinyl]-3-oxopentanoate
|
|
C17H20N2O7 |
详情 |
详情
|
(V) |
33041 |
4-dodecylbenzenesulfonyl chloride
|
|
C18H29ClO2S |
详情 |
详情
|
(VI) |
33042 |
4-dodecylbenzenesulfonyl azide
|
|
C18H29N3O2S |
详情 |
详情
|
(VII) |
30150 |
(3S,4R)-3-((1R)-1-Hydroxyethyl)-4[(1R)-1-methyl-3-diazo-3-(p-nitrobenzyloxycarbonyl)-2-oxopropyl]azetidin-2-one |
137391-68-5 |
C17H18N4O7 |
详情 | 详情
|
(VIII) |
13224 |
4-nitrobenzyl (4R,5R,6S)-3-[(diphenoxyphosphoryl)oxy]-6-[(1R)-1-hydroxyethyl]-4-methyl-7-oxo-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylate
|
90776-59-3 |
C29H27N2O10P |
详情 | 详情
|
合成路线10
该中间体在本合成路线中的序号:
(VIII) Coupling of carbapenem phosphate (VIII) with thiol (XIII) using diisopropylethylamine gave rise to sulfide (XIX). Hydrogenolysis of the p-nitrobenzyl group of (XIX) with simultaneous azide reduction in the presence of Pd/C provided (XX). Treatment of p-nitrobenzyl chloroformate (XXI) with p-nitrophenol (XXII) afforded the nitrophenyl carbonate (XXIII), which was coupled with L-valine (XXIV), yielding carbamate (XXV). Activation of (XXV) with N-hydroxy succinimide and DCC then produced the succinimidyl ester (XXVI). Amine (XX) was coupled with succinimidyl ester (XXVI) to furnish amide (XXVII). The p-nitrobenzyl ester was finally removed by hydrogenation over Pd/C to provide the title compound.
【1】
Lin, Y.-I.; et al.; Peptidic prodrugs of novel aminomethyl-THF 1beta-methylcarbapenems. Bioorg Med Chem Lett 1997, 7, 13, 1665.
|
【2】
Lin, Y.-I.; Bitha, P.; Sakya, S.; Strohmeyer, T.W.; Bush, K. (American Cyanamid Co.); Novel 2-thiosubstd. carbapenems. CA 2118961; EP 0617036; JP 1994321948; US 5602118 .
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(VIII) |
13224 |
4-nitrobenzyl (4R,5R,6S)-3-[(diphenoxyphosphoryl)oxy]-6-[(1R)-1-hydroxyethyl]-4-methyl-7-oxo-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylate
|
90776-59-3 |
C29H27N2O10P |
详情 | 详情
|
(XIII) |
33047 |
(2R,3R)-2-(azidomethyl)tetrahydro-3-furanthiol; (2R,3R)-2-(azidomethyl)tetrahydro-3-furanylhydrosulfide
|
|
C5H9N3OS |
详情 |
详情
|
(XIX) |
33053 |
4-nitrobenzyl (4R,5S,6S)-3-[[(2R,3R)-2-(azidomethyl)tetrahydro-3-furanyl]sulfanyl]-6-[(1R)-1-hydroxyethyl]-4-methyl-7-oxo-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylate
|
|
C22H25N5O7S |
详情 |
详情
|
(XX) |
33054 |
(4R,5S,6S)-3-[[(2R,3R)-2-(aminomethyl)tetrahydro-3-furanyl]sulfanyl]-6-[(1R)-1-hydroxyethyl]-4-methyl-7-oxo-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid
|
|
C15H22N2O5S |
详情 |
详情
|
(XXI) |
33055 |
1-[[(chlorocarbonyl)oxy]methyl]-4-nitrobenzene
|
4457-32-3 |
C8H6ClNO4 |
详情 | 详情
|
(XXII) |
11236 |
4-Nitrophenol; p-Nitrophenol
|
100-02-7 |
C6H5NO3 |
详情 | 详情
|
(XXIII) |
33056 |
4-nitrobenzyl 4-nitrophenyl carbonate
|
|
C14H10N2O7 |
详情 |
详情
|
(XXIV) |
21056 |
(R)-(-)-Valine; D-Valine; (R)-alpha-Aminoisovaleric acid
|
640-68-6 |
C5H11NO2 |
详情 | 详情
|
(XXV) |
33057 |
(2S)-3-methyl-2-([[(4-nitrobenzyl)oxy]carbonyl]amino)butyric acid
|
|
C13H16N2O6 |
详情 |
详情
|
(XXVI) |
33058 |
4-nitrobenzyl (1S)-1-[[(2,5-dioxo-1-pyrrolidinyl)oxy]carbonyl]-2-methylpropylcarbamate
|
|
C17H19N3O8 |
详情 |
详情
|
(XXVII) |
33059 |
(4R,5S,6S)-6-[(1R)-1-hydroxyethyl]-4-methyl-3-[[(2R,3R)-2-([[(2S)-3-methyl-2-([[(4-nitrobenzyl)oxy]carbonyl]amino)butanoyl]amino]methyl)tetrahydro-3-furanyl]sulfanyl]-7-oxo-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid
|
|
C28H36N4O10S |
详情 |
详情
|
合成路线11
该中间体在本合成路线中的序号:
(VIII) A convergent synthesis was further developed. Azide (XII) was reduced to the corresponding amine (XXVIII) employing triethyl phosphite. Hydrolysis of the thioacetate ester of (XXVIII) then gave thiol (XXIX). Coupling of (XXIX) with protected valine succinimidyl ester (XXVI) produced amide (XXX). Condensation of (XXX) with carbapenem phosphate (VIII) yielded adduct (XXXI). The p-nitrobenzyl esters were finally deprotected by catalytic hydrogenation.
【1】
Lin, Y.I.; Li, Z.; Bitha, P.; Convergent synthesis of oral 1beta-methylcarbapenems. J Antibiot 1999, 52, 7, 643.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(VIII) |
13224 |
4-nitrobenzyl (4R,5R,6S)-3-[(diphenoxyphosphoryl)oxy]-6-[(1R)-1-hydroxyethyl]-4-methyl-7-oxo-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylate
|
90776-59-3 |
C29H27N2O10P |
详情 | 详情
|
(XII) |
33046 |
S-[(2R,3R)-2-(azidomethyl)tetrahydro-3-furanyl] ethanethioate
|
|
C7H11N3O2S |
详情 |
详情
|
(XXVI) |
33058 |
4-nitrobenzyl (1S)-1-[[(2,5-dioxo-1-pyrrolidinyl)oxy]carbonyl]-2-methylpropylcarbamate
|
|
C17H19N3O8 |
详情 |
详情
|
(XXVIII) |
33060 |
S-[(2R,3R)-2-(aminomethyl)tetrahydro-3-furanyl] ethanethioate
|
|
C7H13NO2S |
详情 |
详情
|
(XXIX) |
33061 |
(2R,3R)-2-(aminomethyl)tetrahydro-3-furanylhydrosulfide; (2R,3R)-2-(aminomethyl)tetrahydro-3-furanthiol
|
|
C5H11NOS |
详情 |
详情
|
(XXX) |
33062 |
4-nitrobenzyl (1S)-2-methyl-1-[([[(2R,3R)-3-sulfanyltetrahydro-2-furanyl]methyl]amino)carbonyl]propylcarbamate
|
|
C18H25N3O6S |
详情 |
详情
|
(XXXI) |
33063 |
4-nitrobenzyl (4R,5S,6S)-6-[(1R)-1-hydroxyethyl]-4-methyl-3-[[(2R,3R)-2-([[(2S)-3-methyl-2-([[(4-nitrobenzyl)oxy]carbonyl]amino)butanoyl]amino]methyl)tetrahydro-3-furanyl]sulfanyl]-7-oxo-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylate
|
|
C35H41N5O12S |
详情 |
详情
|
合成路线12
该中间体在本合成路线中的序号:
(XII) The protection of 4(R)-hydroxypyrrolidin-2-one (I) first with TBDMS-Cl and then with Boc2O gives the fully protected compound (II), which is condensed with the Grignard reagent of the 4-bromobenzaldehyde dimethyl acetal (III) yielding after working up the substituted benzaldehyde (IV). The reduction of (IV) with NaBH4 affords the benzyl alcohol (V), which is treated with methanesulfonyl chloride to give the corresponding mesylate (VI). The reaction of (VI) with methylamine, followed by protection with Boc2O yields the protected secondary amine (VII), which is desilylated with tetrabutylammonium fluoride to afford the pyrrolidinol (VIII). The reaction of (VIII) with MsCl gives the mesylate (IX), which is treated with potassium thioacetate to provide the acetylsulfanyl derivative (X). The hydrolysis and deprotection of (X) with HCl yields the pyrrolidinethiol (XI), which is condensed with the carbapenem phosphoric ester (XII) to afford the final 4-nitrobenzyl ester intermediate (XIII). Finally, this compound is debenzylated by hydrogenation with H2 over Pd/C.
【1】
Sato, H.; Morishima, H.; Sakuraba, S.; Yamada, K.; Imamura, H.; Shimizu, A.; Sugimoto, Y.; Practical synthesis of a 1beta-methylcarbapenem, J-111,225, using 4-mercapto-2-[4-(N-methylaminomethyl)phenyl]pyrrolidine as a precursor. Chem Pharm Bull 2001, 49, 4, 476. |
【2】
Imamura, H.; et al.; Discovery of novel trans-3,5-disubstituted pyrrolidinylthio-1beta-methylcarbapenems. Bioorg Med Chem 2000, 8, 8, 1969.
|
【3】
Sato, H.; Shimizu, A.; Imamura, H.; et al.; J-111,225, a novel trans-3,5-disubstituted pyrrolidinylthio 1beta-methylcarbapenem; synthesis and physicochemical properties. 38th Intersci Conf Antimicrob Agents Chemother (Sept 24 1998, San Diego) 1998, Abst F-61. |
【4】
Imamura, H.; Ohtake, N.; Shimizu, A.; et al.; Structure-activity relationships of trans-3,5-disubstituted pyrrolidinylthio-1beta-methylcarbapenems. Part 2: J-111,225, J-114,870, J-114,871 and related compounds. Bioorg Med Chem Lett 2000, 10, 2, 115.
|
【5】
Ushijima, R.; Sugimoto, Y.; Shimizu, A.; Kiyonaga, H.; Nagano, R.; Nakagawa, S.; Sakuraba, S.; Sato, H.; Hashizume, T.; Nakano, M.; Imamura, H.; Fukatsu, H. (Banyu Pharmaceutical Co., Ltd.); Carbapenem derivs.. EP 1048669; JP 2000143512; WO 9931106 . |
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
30864 |
N-Benzyl-N-(1(R)-phenylethyl)amide lithium salt
|
|
C15H16LiN |
详情 |
详情
|
(II) |
30850 |
tert-butyl (4R)-4-[[tert-butyl(dimethyl)silyl]oxy]-2-oxo-1-pyrrolidinecarboxylate
|
|
C15H29NO4Si |
详情 |
详情
|
(III) |
30851 |
bromo[4-(dimethoxymethyl)phenyl]magnesium
|
|
C9H11BrMgO2 |
详情 |
详情
|
(IV) |
30852 |
tert-butyl (2R,4R)-4-[[tert-butyl(dimethyl)silyl]oxy]-2-(4-formylphenyl)-1-pyrrolidinecarboxylate
|
|
C22H35NO4Si |
详情 |
详情
|
(V) |
30870 |
tert-butyl (2R,4R)-4-[[tert-butyl(dimethyl)silyl]oxy]-2-[4-(hydroxymethyl)phenyl]-1-pyrrolidinecarboxylate
|
|
C22H37NO4Si |
详情 |
详情
|
(VI) |
30871 |
tert-butyl (2R,4R)-4-[[tert-butyl(dimethyl)silyl]oxy]-2-[4-([[methyl(dimethylene)-lambda(6)-sulfanyl]oxy]methyl)phenyl]-1-pyrrolidinecarboxylate
|
|
C25H43NO4SSi |
详情 |
详情
|
(VII) |
30872 |
tert-butyl (2R,4R)-2-(4-[[(tert-butoxycarbonyl)(methyl)amino]methyl]phenyl)-4-[[tert-butyl(dimethyl)silyl]oxy]-1-pyrrolidinecarboxylate
|
|
C28H48N2O5Si |
详情 |
详情
|
(VIII) |
30873 |
tert-butyl (2R,4R)-2-(4-[[(tert-butoxycarbonyl)(methyl)amino]methyl]phenyl)-4-hydroxy-1-pyrrolidinecarboxylate
|
|
C22H34N2O5 |
详情 |
详情
|
(IX) |
30874 |
tert-butyl (2R,4R)-2-(4-[[(tert-butoxycarbonyl)(methyl)amino]methyl]phenyl)-4-[[methyl(dimethylene)-lambda(6)-sulfanyl]oxy]-1-pyrrolidinecarboxylate
|
|
C25H40N2O5S |
详情 |
详情
|
(X) |
30875 |
tert-butyl (2R,4R)-4-(acetylsulfanyl)-2-(4-[[(tert-butoxycarbonyl)(methyl)amino]methyl]phenyl)-1-pyrrolidinecarboxylate
|
|
C24H36N2O5S |
详情 |
详情
|
(XI) |
30876 |
(3S,5R)-5-[4-[(methylamino)methyl]phenyl]pyrrolidinylhydrosulfide; (3S,5R)-5-[4-[(methylamino)methyl]phenyl]-3-pyrrolidinethiol
|
|
C12H18N2S |
详情 |
详情
|
(XII) |
13224 |
4-nitrobenzyl (4R,5R,6S)-3-[(diphenoxyphosphoryl)oxy]-6-[(1R)-1-hydroxyethyl]-4-methyl-7-oxo-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylate
|
90776-59-3 |
C29H27N2O10P |
详情 | 详情
|
(XIII) |
30877 |
4-nitrobenzyl (4R,5S,6S)-6-[(1R)-1-hydroxyethyl]-4-methyl-3-[((3S,5R)-5-[4-[(methylamino)methyl]phenyl]pyrrolidinyl)sulfanyl]-7-oxo-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylate
|
|
C29H34N4O6S |
详情 |
详情
|
合成路线13
该中间体在本合成路线中的序号:
(XII) (R)-4-hydroxy-2-pyrrolidinone (I) was protected as the tert-butyldimethylsilyl ether, and then converted to tert-butyl carbamate (II) by means of Boc2O. Subsequent condensation of (II) with Grignard reagent (III), followed by reduction with NaBH4, and acetal hydrolysis yielded the pyrrolidinyl benzaldehyde (IV). Horner-Emmons reaction of (IV) with phosphonate (V) produced the cinnamic acid derivative (VI), and further Michael addition of the chiral lithium amide (VII) furnished aminoester (VIII). After hydrogenolysis of both N-benzyl groups of (VIII), the resulting primary amine (IX) was protected with Boc2O, and the silyl ether was then cleaved by means of tetrabutylammonium fluoride to give the hydroxypyrrolidine derivative (X). This was converted to the required thiol (XI), which was then coupled with the carbapenem phosphate (XII). Finally, hydrogenolysis of the 4-nitrobenzyl ester of (XII) provided the title compound.
【1】
Imamura, H.; et al.; Discovery of novel trans-3,5-disubstituted pyrrolidinylthio-1beta-methylcarbapenems. Bioorg Med Chem 2000, 8, 8, 1969.
|
【2】
Sato, H.; Shimizu, A.; Imamura, H.; et al.; J-111,225, a novel trans-3,5-disubstituted pyrrolidinylthio 1beta-methylcarbapenem; synthesis and physicochemical properties. 38th Intersci Conf Antimicrob Agents Chemother (Sept 24 1998, San Diego) 1998, Abst F-61. |
【3】
Imamura, H.; Sato, H.; Shimizu, A.; et al.; J-114,870 and J-114,871, novel trans-3,5-disubstituted pyrrolidinylthio 1beta-methylcarbapenems: Synthesis and physicochemical properties. 38th Intersci Conf Antimicrob Agents Chemother (Sept 24 1998, San Diego) 1998, Abst F-56. |
【4】
Imamura, H.; Ohtake, N.; Shimizu, A.; et al.; Structure-activity relationships of trans-3,5-disubstituted pyrrolidinylthio-1beta-methylcarbapenems. Part 2: J-111,225, J-114,870, J-114,871 and related compounds. Bioorg Med Chem Lett 2000, 10, 2, 115.
|
【5】
Ushijima, R.; Sugimoto, Y.; Shimizu, A.; Kiyonaga, H.; Nagano, R.; Nakagawa, S.; Sakuraba, S.; Sato, H.; Hashizume, T.; Nakano, M.; Imamura, H.; Fukatsu, H. (Banyu Pharmaceutical Co., Ltd.); Carbapenem derivs.. EP 1048669; JP 2000143512; WO 9931106 . |
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
30864 |
N-Benzyl-N-(1(R)-phenylethyl)amide lithium salt
|
|
C15H16LiN |
详情 |
详情
|
(II) |
30850 |
tert-butyl (4R)-4-[[tert-butyl(dimethyl)silyl]oxy]-2-oxo-1-pyrrolidinecarboxylate
|
|
C15H29NO4Si |
详情 |
详情
|
(III) |
30851 |
bromo[4-(dimethoxymethyl)phenyl]magnesium
|
|
C9H11BrMgO2 |
详情 |
详情
|
(IV) |
30852 |
tert-butyl (2R,4R)-4-[[tert-butyl(dimethyl)silyl]oxy]-2-(4-formylphenyl)-1-pyrrolidinecarboxylate
|
|
C22H35NO4Si |
详情 |
详情
|
(VI) |
30853 |
tert-butyl (2R,4R)-4-[[tert-butyl(dimethyl)silyl]oxy]-2-[4-[(E)-3-ethoxy-3-oxo-1-propenyl]phenyl]-1-pyrrolidinecarboxylate
|
|
C26H41NO5Si |
详情 |
详情
|
(VII) |
30864 |
N-Benzyl-N-(1(R)-phenylethyl)amide lithium salt
|
|
C15H16LiN |
详情 |
详情
|
(VIII) |
30865 |
tert-butyl (2R,4R)-2-[4-((1S)-1-[benzyl[(1R)-1-phenylethyl]amino]-3-ethoxy-3-oxopropyl)phenyl]-4-[[tert-butyl(dimethyl)silyl]oxy]-1-pyrrolidinecarboxylate
|
|
C41H58N2O5Si |
详情 |
详情
|
(IX) |
30866 |
tert-butyl (2R,4R)-2-[4-[(1S)-1-amino-3-ethoxy-3-oxopropyl]phenyl]-4-[[tert-butyl(dimethyl)silyl]oxy]-1-pyrrolidinecarboxylate
|
|
C26H44N2O5Si |
详情 |
详情
|
(X) |
30867 |
tert-butyl (2R,4R)-2-(4-[(1S)-1-[(tert-butoxycarbonyl)amino]-3-ethoxy-3-oxopropyl]phenyl)-4-hydroxy-1-pyrrolidinecarboxylate
|
|
C25H38N2O7 |
详情 |
详情
|
(XI) |
30868 |
(3S)-3-amino-3-[4-[(2R,4S)-4-sulfanylpyrrolidinyl]phenyl]propanamide
|
|
C13H19N3OS |
详情 |
详情
|
(XII) |
13224 |
4-nitrobenzyl (4R,5R,6S)-3-[(diphenoxyphosphoryl)oxy]-6-[(1R)-1-hydroxyethyl]-4-methyl-7-oxo-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylate
|
90776-59-3 |
C29H27N2O10P |
详情 | 详情
|
合成路线14
该中间体在本合成路线中的序号:
(XII) (R)-4-hydroxy-2-pyrrolidinone (I) was protected as the tert-butyldimethylsilyl ether, and then converted to tert-butyl carbamate (II) by means of Boc2O. Subsequent condensation of (II) with Grignard reagent (III), followed by reduction with NaBH4, and acetal hydrolysis yielded the pyrrolidinyl benzaldehyde (IV). Horner-Emmons reaction of (IV) with phosphonate (V) produced the cinnamic acid derivative (VI), and further Michael addition to (VI) of the chiral lithium amide (VII) furnished aminoester (VIII). After hydrogenolysis of both N-benzyl groups of (VIII), the resulting primary amine (IX) was protected with Boc2O, and the silyl ether was then cleaved by means of tetrabutylammonium fluoride to give the hydroxypyrrolidine derivative (X). This was converted to the required thiol (XI), which was then coupled with the carbapenem phosphate (XII). Finally, hydrogenolysis of the 4-nitrobenzyl ester of (XII) provided the title compound.
【1】
Imamura, H.; et al.; Discovery of novel trans-3,5-disubstituted pyrrolidinylthio-1beta-methylcarbapenems. Bioorg Med Chem 2000, 8, 8, 1969.
|
【2】
Imamura, H.; Sato, H.; Shimizu, A.; et al.; J-114,870 and J-114,871, novel trans-3,5-disubstituted pyrrolidinylthio 1beta-methylcarbapenems: Synthesis and physicochemical properties. 38th Intersci Conf Antimicrob Agents Chemother (Sept 24 1998, San Diego) 1998, Abst F-56. |
【3】
Sato, H.; Shimizu, A.; Imamura, H.; et al.; J-111,225, a novel trans-3,5-disubstituted pyrrolidinylthio 1beta-methylcarbapenem; synthesis and physicochemical properties. 38th Intersci Conf Antimicrob Agents Chemother (Sept 24 1998, San Diego) 1998, Abst F-61. |
【4】
Imamura, H.; Ohtake, N.; Shimizu, A.; et al.; Structure-activity relationships of trans-3,5-disubstituted pyrrolidinylthio-1beta-methylcarbapenems. Part 2: J-111,225, J-114,870, J-114,871 and related compounds. Bioorg Med Chem Lett 2000, 10, 2, 115.
|
【5】
Ushijima, R.; Sugimoto, Y.; Shimizu, A.; Kiyonaga, H.; Nagano, R.; Nakagawa, S.; Sakuraba, S.; Sato, H.; Hashizume, T.; Nakano, M.; Imamura, H.; Fukatsu, H. (Banyu Pharmaceutical Co., Ltd.); Carbapenem derivs.. EP 1048669; JP 2000143512; WO 9931106 . |
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
|
10019 |
Ethyl 2-(diethoxyphosphoryl)acetate; Triethyl phosphonoacetate
|
867-13-0 |
C8H17O5P |
详情 | 详情
|
(I) |
30864 |
N-Benzyl-N-(1(R)-phenylethyl)amide lithium salt
|
|
C15H16LiN |
详情 |
详情
|
(II) |
30850 |
tert-butyl (4R)-4-[[tert-butyl(dimethyl)silyl]oxy]-2-oxo-1-pyrrolidinecarboxylate
|
|
C15H29NO4Si |
详情 |
详情
|
(III) |
30851 |
bromo[4-(dimethoxymethyl)phenyl]magnesium
|
|
C9H11BrMgO2 |
详情 |
详情
|
(IV) |
30852 |
tert-butyl (2R,4R)-4-[[tert-butyl(dimethyl)silyl]oxy]-2-(4-formylphenyl)-1-pyrrolidinecarboxylate
|
|
C22H35NO4Si |
详情 |
详情
|
(VI) |
30853 |
tert-butyl (2R,4R)-4-[[tert-butyl(dimethyl)silyl]oxy]-2-[4-[(E)-3-ethoxy-3-oxo-1-propenyl]phenyl]-1-pyrrolidinecarboxylate
|
|
C26H41NO5Si |
详情 |
详情
|
(VII) |
30854 |
N-Benzyl-N-(1(S)-phenylethyl)amide lithium salt
|
|
C15H16LiN |
详情 |
详情
|
(VIII) |
30855 |
tert-butyl (2R,4R)-2-[4-((1R)-1-[benzyl[(1S)-1-phenylethyl]amino]-3-ethoxy-3-oxopropyl)phenyl]-4-[[tert-butyl(dimethyl)silyl]oxy]-1-pyrrolidinecarboxylate
|
|
C41H58N2O5Si |
详情 |
详情
|
(IX) |
30856 |
tert-butyl (2R,4R)-2-[4-[(1R)-1-amino-3-ethoxy-3-oxopropyl]phenyl]-4-[[tert-butyl(dimethyl)silyl]oxy]-1-pyrrolidinecarboxylate
|
|
C26H44N2O5Si |
详情 |
详情
|
(X) |
30857 |
tert-butyl (2R,4R)-2-(4-[(1R)-1-[(tert-butoxycarbonyl)amino]-3-ethoxy-3-oxopropyl]phenyl)-4-hydroxy-1-pyrrolidinecarboxylate
|
|
C25H38N2O7 |
详情 |
详情
|
(XI) |
30858 |
(3R)-3-amino-3-[4-[(2R,4S)-4-sulfanylpyrrolidinyl]phenyl]propanamide
|
|
C13H19N3OS |
详情 |
详情
|
(XII) |
13224 |
4-nitrobenzyl (4R,5R,6S)-3-[(diphenoxyphosphoryl)oxy]-6-[(1R)-1-hydroxyethyl]-4-methyl-7-oxo-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylate
|
90776-59-3 |
C29H27N2O10P |
详情 | 详情
|
合成路线15
该中间体在本合成路线中的序号:
(XVI) Condensation of (phosphoryloxy)carbapenem (XVI) with 3-mercapto-1-(1,3-thiazolin-2-yl)azetidine (XI) gave thioether (XVII). The p-nitrobenzyl ester group of (XVII) was then deprotected with Zn powder to afford carboxylic acid. Finally, treatment of (XVIII) with either iodo or chloromethyl pivalate (XIX) produced the target compound.
【1】
Satoh, C.; Mihira, A.; Yamamoto, S.; Hayashi, K.; Kitamura, M.; Tamai, S.; Abe, T.; Kumagai, T.; Hikida, M.; L-084, a new oral carbapenem: Synthesis and structure-activity relationships of C2-substituted 1beta-methylcarbapenems. 38th Intersci Conf Antimicrob Agents Chemother (Sept 24 1998, San Diego) 1998, Abst F-64. |
【2】
Abe, T.; Isoda, T.; Sato, C.; Mihira, A.; Tamai, S.; Kumagai, T. (Lederle (Japan), Ltd.); 2-(1-(1,3-Thiazolin-2-yl)azetidin-3-yl)thio-carbapenem derivs.. EP 0632039; EP 0717042; JP 1996053453; US 5534510; US 5659043; US 5783703 .
|
【3】
Abe, T.; Kumagai, T. (Lederle (Japan), Ltd.); Carbapenem-3-carboxylic acid ester derivs.. EP 0808315; JP 1999504039; US 5886172; WO 9721712 .
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(XIXa) |
11159 |
iodomethyl pivalate
|
|
C6H11IO2 |
详情 |
详情
|
(XIXb) |
16166 |
chloromethyl pivalate
|
18997-19-8 |
C6H11ClO2 |
详情 | 详情
|
(XI) |
31404 |
1-(4,5-dihydro-1,3-thiazol-2-yl)-3-azetidinylhydrosulfide; 1-(4,5-dihydro-1,3-thiazol-2-yl)-3-azetidinethiol
|
179337-57-6 |
C6H10N2S2 |
详情 | 详情
|
(XVI) |
13224 |
4-nitrobenzyl (4R,5R,6S)-3-[(diphenoxyphosphoryl)oxy]-6-[(1R)-1-hydroxyethyl]-4-methyl-7-oxo-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylate
|
90776-59-3 |
C29H27N2O10P |
详情 | 详情
|
(XVII) |
31408 |
4-nitrobenzyl (4R,5S,6S)-3-[[1-(4,5-dihydro-1,3-thiazol-2-yl)-3-azetidinyl]sulfanyl]-6-[(1R)-1-hydroxyethyl]-4-methyl-7-oxo-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylate
|
|
C23H26N4O6S2 |
详情 |
详情
|
(XVIII) |
31409 |
(4R,5S,6S)-3-[[1-(4,5-dihydro-1,3-thiazol-2-yl)-3-azetidinyl]sulfanyl]-6-[(1R)-1-hydroxyethyl]-4-methyl-7-oxo-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid
|
|
C16H21N3O4S2 |
详情 |
详情
|
合成路线16
该中间体在本合成路线中的序号:
(VI) Mercaptoproline derivative (I) was condensed with protected piperazine (II) via activation with carbonyl diimidazole to afford amide (III). The 4-methoxybenzyl group of (III) was then removed with trifluoromethanesulfonic acid in the presence of anisole and trifluoroacetic acid, and the resulting mercaptan (IV) was condensed with carbapenem phosphate (VI), (prepared from ketone (V) and diphenylphosphorochloridate), to afford thioether (VII). N-Methylation was carried out using methyl fluorosulfonate to yield quaternary ammonium salt (VIII). Finally, the 4-nitrobenzyl ester and carbamate groups of (VIII) were eliminated by hydrogenation in the presence of Pd/C, and the target product was isolated by ion-exchange chromatography.
【1】
Ishikawa, K.; Kojima, K.; Miyauchi, M.; Endo, R.; Yasuda H; Kawamoto I.; Synthesis and structure-activity relationships of 1beta-methylcarbapenems with quaternary ammonium side chains. J Antibiot 1998, 51, 8, 757.
|
【2】
Kawamoto, I.; Miyauchi, M.; Nakayama, E.; Endo, R.; Ohya, S.; Utsui, Y. (Sankyo Co., Ltd.); Carbapenem derivs. having antibiotic activity, their preparation and their use. EP 0443883; JP 1992211083; US 5310735 .
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
26808 |
(2S,4S)-4-[(4-methoxybenzyl)sulfanyl]-1-methyl-2-pyrrolidinecarboxylic acid
|
|
C14H19NO3S |
详情 |
详情
|
(II) |
26809 |
4-nitrophenyl 1-piperazinecarboxylate
|
|
C11H13N3O4 |
详情 |
详情
|
(III) |
26810 |
4-nitrobenzyl 4-([(2S,4S)-4-[(4-methoxybenzyl)sulfanyl]-1-methylpyrrolidinyl]carbonyl)-1-piperazinecarboxylate
|
|
C26H32N4O6S |
详情 |
详情
|
(IV) |
26811 |
4-nitrobenzyl 4-[[(2S,4S)-1-methyl-4-sulfanylpyrrolidinyl]carbonyl]-1-piperazinecarboxylate
|
|
C18H24N4O5S |
详情 |
详情
|
(V) |
22575 |
4-nitrobenzyl (2R,5R,6S)-6-[(1R)-1-hydroxyethyl]-4-methyl-3,7-dioxo-1-azabicyclo[3.2.0]heptane-2-carboxylate
|
|
C17H18N2O7 |
详情 |
详情
|
(VI) |
13224 |
4-nitrobenzyl (4R,5R,6S)-3-[(diphenoxyphosphoryl)oxy]-6-[(1R)-1-hydroxyethyl]-4-methyl-7-oxo-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylate
|
90776-59-3 |
C29H27N2O10P |
详情 | 详情
|
(VII) |
26812 |
4-nitrobenzyl (4R,5S,6S)-6-[(1R)-1-hydroxyethyl]-4-methyl-3-([(3S,5S)-1-methyl-5-[(4-[[(4-nitrobenzyl)oxy]carbonyl]-1-piperazinyl)carbonyl]pyrrolidinyl]sulfanyl)-7-oxo-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylate
|
|
C35H40N6O11S |
详情 |
详情
|
(VIII) |
26813 |
(1R,5S,6S)-6-(1(R)-Hydroxyethyl)-2-[1,1-dimethyl-5(S)-[4-(4-nitrobenzyloxycarbonyl)piperazin-1-ylcarbonyl]pyrrrolidinium-3(S)-ylsulfanyl]-1-methyl-1-carba-2-penem-3-carboxylic acid 4-nitrobenzyl ester fluorosulfonate; (1R,5S,6S)-6-(1(R)-Hydroxyethyl)-2-[1,1-dimethyl-5(S)-[4-(4-nitrobenzyloxycarbonyl)piperazin-1-ylcarbonyl]pyrrrolidinium-3(S)-ylsulfanyl]-1-methyl-1-carba-2-penem-3-carboxylic acid 4-nitrobenzyl ester fluorosulfonate |
|
C36H43FN6O14S2 |
详情 |
详情
|
合成路线17
该中间体在本合成路线中的序号:
(VI) Mercaptoproline derivative (I) was condensed with N-(carbamoylmethyl)homopiperazine (II) via activation with carbonyl diimidazole to afford amide (III). The 4-methoxybenzyl group of (III) was then removed with trifluoromethanesulfonic acid in the presence of anisole and trifluoroacetic acid, and the resulting mercaptan (IV) was condensed with carbapenem phosphate (VI), (prepared from ketone (V) and diphenylphosphorochloridate), to afford thioether (VII). N-Methylation of (VII) was carried out using methyl fluorosulfonate to yield quaternary ammonium salt (VIII). Finally, the 4-nitrobenzyl ester and carbamate groups of (VIII) were eliminated by hydrogenation in the presence of Pd/C, and the target product was isolated by ion-exchange chromatography.
【1】
Ishikawa, K.; Kojima, K.; Miyauchi, M.; Endo, R.; Yasuda H; Kawamoto I.; Synthesis and structure-activity relationships of 1beta-methylcarbapenems with quaternary ammonium side chains. J Antibiot 1998, 51, 8, 757.
|
【2】
Kawamoto, I.; Miyauchi, M.; Nakayama, E.; Endo, R.; Ohya, S.; Utsui, Y. (Sankyo Co., Ltd.); Carbapenem derivs. having antibiotic activity, their preparation and their use. EP 0443883; JP 1992211083; US 5310735 .
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
26814 |
(2S,4S)-4-[(4-methoxybenzyl)sulfanyl]-1-[[(4-nitrobenzyl)oxy]carbonyl]-2-pyrrolidinecarboxylic acid
|
|
C21H22N2O7S |
详情 |
详情
|
(II) |
26815 |
2-(1,4-diazepan-1-yl)acetamide
|
|
C7H15N3O |
详情 |
详情
|
(III) |
26816 |
4-nitrobenzyl (2S,4S)-2-[[4-(2-amino-2-oxoethyl)-1,4-diazepan-1-yl]carbonyl]-4-[(4-methoxybenzyl)sulfanyl]-1-pyrrolidinecarboxylate
|
|
C28H35N5O7S |
详情 |
详情
|
(IV) |
26817 |
4-nitrobenzyl (2S,4S)-2-[[4-(2-amino-2-oxoethyl)-1,4-diazepan-1-yl]carbonyl]-4-sulfanyl-1-pyrrolidinecarboxylate
|
|
C20H27N5O6S |
详情 |
详情
|
(V) |
22575 |
4-nitrobenzyl (2R,5R,6S)-6-[(1R)-1-hydroxyethyl]-4-methyl-3,7-dioxo-1-azabicyclo[3.2.0]heptane-2-carboxylate
|
|
C17H18N2O7 |
详情 |
详情
|
(VI) |
13224 |
4-nitrobenzyl (4R,5R,6S)-3-[(diphenoxyphosphoryl)oxy]-6-[(1R)-1-hydroxyethyl]-4-methyl-7-oxo-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylate
|
90776-59-3 |
C29H27N2O10P |
详情 | 详情
|
(VII) |
26818 |
4-nitrobenzyl (4R,5S,6S)-3-[((3S,5S)-5-[[4-(2-amino-2-oxoethyl)-1,4-diazepan-1-yl]carbonyl]-1-[[(4-nitrobenzyl)oxy]carbonyl]pyrrolidinyl)sulfanyl]-6-[(1R)-1-hydroxyethyl]-4-methyl-7-oxo-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylate
|
|
C37H43N7O12S |
详情 |
详情
|
(VIII) |
26819 |
(1R,5S,6S)-2-[5(S)-[4-(carbamoylmethyl)-4-methylperhydro-1,4-diazepinium-1-ylcarbonyl]-1-(4-nitrobenzyloxycarbonyl)pyrrolidin-3-(S)-ylsulfanyl]-6-(1(R)-hydroxyethyl)-1-methyl-1-carba-2-penem-3-carboxylic acid 4-nitrobenzyl ester fluorosulfonate; (1R,5S,6S)-2-[5(S)-[4-(carbamoylmethyl)-4-methylperhydro-1,4-diazepinium-1-ylcarbonyl]-1-(4-nitrobenzyloxycarbonyl)pyrrolidin-3-(S)-ylsulfanyl]-6-(1(R)-hydroxyethyl)-1-methyl-1-carba-2-penem-3-carboxylic acid 4-nitrobenzyl ester fluorosulfonate |
|
C38H46FN7O15S2 |
详情 |
详情
|
合成路线18
该中间体在本合成路线中的序号:
(VIII) L-Tartaric acid (I) was converted to succinimimide (II) upon treatment with benzylamine in refluxing xylene with azeotropic removal of water. Subsequent reduction of (II) with borane, generated from NaBH4 and BF3, afforded pyrrolidine (III). Removal of the N-benzyl group of (III) was effected by hydrogenolysis over Pd/C, and the resulting secondary amine (IV) was coupled with the N-protected 3-thioacetylproline (V) to furnish amide (VI). Deacetylation of (VI) under basic conditions provided thiol (VII). Condensation of thiol (VII) with carbapenem enolphosphate (VIII) afforded thioether (IX). The 4-nitrobenzyl protecting groups of (IX) were finally removed by hydrogenolysis over Pd/C.
【1】
Park, S.W.; Park, S.Y.; Kim, D.J.; Shin, K.J.; Kang, Y.K.; Yoo, K.H.; Jae Seo, K.; Synthesis and biological evaluation of novel 1beta-methylcarbapenems having a new moiety at C-2. Bioorg Med Chem Lett 1999, 9, 16, 2385.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
16695 |
(2S,3S)-2,3-dihydroxybutanedioic acid; D-(-)-Tartaric Acid; D-Tartaric Acid; (2S,3S)-2,3-dihydroxysuccinic acid
|
147-71-7 |
C4H6O6 |
详情 | 详情
|
(II) |
33017 |
(3R,4R)-1-benzyl-3,4-dihydroxy-2,5-pyrrolidinedione
|
75172-31-5 |
C11H11NO4 |
详情 | 详情
|
(III) |
33018 |
(3S,4S)-1-benzyl-3,4-pyrrolidinediol
|
|
C11H15NO2 |
详情 |
详情
|
(IV) |
33019 |
(3S,4S)-3,4-pyrrolidinediol
|
|
C4H9NO2 |
详情 |
详情
|
(V) |
18241 |
(2S,4S)-4-(acetylsulfanyl)-1-[[(4-nitrobenzyl)oxy]carbonyl]-2-pyrrolidinecarboxylic acid
|
|
C15H16N2O7S |
详情 |
详情
|
(VI) |
33020 |
4-nitrobenzyl (2S,4S)-4-(acetylsulfanyl)-2-[[(3S,4S)-3,4-dihydroxypyrrolidinyl]carbonyl]-1-pyrrolidinecarboxylate
|
|
C19H23N3O8S |
详情 |
详情
|
(VII) |
33021 |
4-nitrobenzyl (2S,4S)-2-[[(3S,4S)-3,4-dihydroxypyrrolidinyl]carbonyl]-4-sulfanyl-1-pyrrolidinecarboxylate
|
|
C17H21N3O7S |
详情 |
详情
|
(VIII) |
13224 |
4-nitrobenzyl (4R,5R,6S)-3-[(diphenoxyphosphoryl)oxy]-6-[(1R)-1-hydroxyethyl]-4-methyl-7-oxo-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylate
|
90776-59-3 |
C29H27N2O10P |
详情 | 详情
|
(IX) |
33022 |
4-nitrobenzyl (4R,5S,6S)-3-[((3S,5S)-5-[[(3S,4S)-3,4-dihydroxypyrrolidinyl]carbonyl]-1-[[(4-nitrobenzyl)oxy]carbonyl]pyrrolidinyl)sulfanyl]-6-[(1R)-1-hydroxyethyl]-4-methyl-7-oxo-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylate
|
|
C34H37N5O13S |
详情 |
详情
|
合成路线19
该中间体在本合成路线中的序号:
(I) Carbapenem-2-diphenylphosphate (I) was condensed with the sodium salt of 2-mercaptobenzothiophene (II) to give thioether (III). The p-nitrobenzyl group of (III) was then deprotected by hydrogenation over Pd/C in the presence of NaHCO3 to afford the corresponding carboxylic acid sodium salt.
【1】
Szumiloski, S.P.; Ratcliffe, R.W.; Waddell, S.T.; et al.; Benzothiazolylthio carbapenems: Potent anti-MRSA agents. Bioorg Med Chem Lett 1995, 5, 13, 1427.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
13224 |
4-nitrobenzyl (4R,5R,6S)-3-[(diphenoxyphosphoryl)oxy]-6-[(1R)-1-hydroxyethyl]-4-methyl-7-oxo-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylate
|
90776-59-3 |
C29H27N2O10P |
详情 | 详情
|
(II) |
37709 |
sodium 1-benzothiophen-2-ylsulfide
|
|
C8H5NaS2 |
详情 |
详情
|
(III) |
37710 |
4-nitrobenzyl (4R,5S,6S)-3-(1-benzothiophen-2-ylsulfanyl)-6-[(1R)-1-hydroxyethyl]-4-methyl-7-oxo-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylate
|
|
C25H22N2O6S2 |
详情 |
详情
|
合成路线20
该中间体在本合成路线中的序号:
(VII) Protection of alcohol (I) with TBDMSCl and imidazole gives silyl compound (II) which is N-methylated by means of NaH and MeI and then deprotected with HCl to yield derivative (III). Mesylation of (III) with MsCl in presence of Et3N followed by thioacetylation with AcSK (A) affords thioacetate (IV) which is then hydrolyzed with NaOMe to yield (V). Treatment of (VI) with diphenylphosphoryl chloride (B) and DIEA in acetonitrile yields (VII), which is then condensed with mercaptan (V) by means of DIEA in the same solvent to provide carbapenem (VIII). Deprotection of the carboxyl moiety of (VIII) by hydrogenation with H2 over Pd/C affords carboxylate (IX), which is finally esterified with pivaloyloxymethyl iodide (X) in N,N-dimethylacetamide or DMF.
【1】
Miyauchi, M.; Ohya, S.; Kawamoto, I.; Shibayama, T.; Kanno, O.; Synthesis and biological evaluation of new oral carbapenems with 1-methyl-5-oxopyrrolidin-3-ylthio moiety. J Antibiot 1999, 52, 10, 900.
|
【2】
Kawamoto, I.; Tanaka, T.; Endo, R.; Miyauchi, M.; Iwata, M. (Sankyo Co., Ltd.); 2-(Heterocyclylthio)carbapenem derivs. their preparation and their use as antibiotics. AU 8932386; EP 0337637; EP 0597821; JP 1990028180; JP 1990049783; US 5104867; US 5242914 . |
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(B) |
16074 |
Diphenyl phosphoryl chloride; 1,1'-Diphenylphosphoryl chloride; Chlorodiphenyl Phosphate; Diphenyl chlorophosphate; Diphenylchlorophosphate
|
2524-64-3 |
C12H10ClO3P |
详情 | 详情
|
(A) |
17190 |
potassium ethanethioate
|
10387-40-3 |
C2H3KOS |
详情 | 详情
|
(I) |
17188 |
(S)-4-hydroxy-2-pyrrolidone; (4S)-4-hydroxytetrahydro-2H-pyrrol-2-one; (S)-4-hydroxypyrrolidone
|
68108-18-9 |
C4H7NO2 |
详情 | 详情
|
(II) |
41640 |
(4S)-4-[[tert-butyl(dimethyl)silyl]oxy]-2-pyrrolidinone
|
|
C10H21NO2Si |
详情 |
详情
|
(III) |
41641 |
(4S)-4-hydroxy-1-methyl-2-pyrrolidinone
|
|
C5H9NO2 |
详情 |
详情
|
(IV) |
41642 |
S-[(3R)-1-methyl-5-oxopyrrolidinyl] ethanethioate
|
|
C7H11NO2S |
详情 |
详情
|
(V) |
41643 |
(4R)-1-methyl-4-sulfanyl-2-pyrrolidinone
|
|
C5H9NOS |
详情 |
详情
|
(VI) |
37720 |
4-nitrobenzyl (4R,5R,6S)-6-[(1R)-1-hydroxyethyl]-4-methyl-3,7-dioxo-1-azabicyclo[3.2.0]heptane-2-carboxylate
|
|
C17H18N2O7 |
详情 |
详情
|
(VII) |
13224 |
4-nitrobenzyl (4R,5R,6S)-3-[(diphenoxyphosphoryl)oxy]-6-[(1R)-1-hydroxyethyl]-4-methyl-7-oxo-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylate
|
90776-59-3 |
C29H27N2O10P |
详情 | 详情
|
(VIII) |
41644 |
4-nitrobenzyl (4R,5S,6S)-6-[(1R)-1-hydroxyethyl]-4-methyl-3-[[(3R)-1-methyl-5-oxopyrrolidinyl]sulfanyl]-7-oxo-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylate
|
|
C22H25N3O7S |
详情 |
详情
|
(IX) |
41645 |
sodium (4R,5S,6S)-6-[(1R)-1-hydroxyethyl]-4-methyl-3-[[(3R)-1-methyl-5-oxopyrrolidinyl]sulfanyl]-7-oxo-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylate
|
|
C15H19N2NaO5S |
详情 |
详情
|
(X) |
11159 |
iodomethyl pivalate
|
|
C6H11IO2 |
详情 |
详情
|
合成路线21
该中间体在本合成路线中的序号:
(VIII) Alcohol (I) is protected with TBDMSCl and imidazole to give silyl compound (II), which is N-methylated by means of NaH and MeI and then deprotected with HCl to yield derivative (III). Mitsunobu reaction of (III) with 4-nitrobenzoic acid in presence of PPh3 and DEAD, followed by ester hydrolysis with K2CO3, provides alcohol (IV). Mesylation of (IV) with MsCl in presence of Et3N, followed by thioacetylation with AcSK (A), affords thioacetate (V), which is then hydrolyzed with NaOMe to yield (VI). Treatment of (VII) with diphenylphosphoryl chloride (B) in CH3CN and DIEA in CH3CN yields (VIII), which is then condensed with mercaptan (VI) by means of DIEA in the same solvent to provide carbapenem (IX). Deprotection of the carboxyl moiety of (IX) by hydrogenation with H2 over Pd/C affords carboxylate (X), which is finally esterified with pivaloyloxymethyl iodide (XI) in N,N-dimethylacetamide or DMF.
【1】
Miyauchi, M.; Ohya, S.; Kawamoto, I.; Shibayama, T.; Kanno, O.; Synthesis and biological evaluation of new oral carbapenems with 1-methyl-5-oxopyrrolidin-3-ylthio moiety. J Antibiot 1999, 52, 10, 900.
|
【2】
Kawamoto, I.; Tanaka, T.; Endo, R.; Miyauchi, M.; Iwata, M. (Sankyo Co., Ltd.); 2-(Heterocyclylthio)carbapenem derivs. their preparation and their use as antibiotics. AU 8932386; EP 0337637; EP 0597821; JP 1990028180; JP 1990049783; US 5104867; US 5242914 . |
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(B) |
16074 |
Diphenyl phosphoryl chloride; 1,1'-Diphenylphosphoryl chloride; Chlorodiphenyl Phosphate; Diphenyl chlorophosphate; Diphenylchlorophosphate
|
2524-64-3 |
C12H10ClO3P |
详情 | 详情
|
(A) |
17190 |
potassium ethanethioate
|
10387-40-3 |
C2H3KOS |
详情 | 详情
|
(I) |
17188 |
(S)-4-hydroxy-2-pyrrolidone; (4S)-4-hydroxytetrahydro-2H-pyrrol-2-one; (S)-4-hydroxypyrrolidone
|
68108-18-9 |
C4H7NO2 |
详情 | 详情
|
(II) |
41640 |
(4S)-4-[[tert-butyl(dimethyl)silyl]oxy]-2-pyrrolidinone
|
|
C10H21NO2Si |
详情 |
详情
|
(III) |
41641 |
(4S)-4-hydroxy-1-methyl-2-pyrrolidinone
|
|
C5H9NO2 |
详情 |
详情
|
(IV) |
41648 |
(4R)-4-hydroxy-1-methyl-2-pyrrolidinone
|
|
C5H9NO2 |
详情 |
详情
|
(V) |
41649 |
S-[(3S)-1-methyl-5-oxopyrrolidinyl] ethanethioate
|
|
C7H11NO2S |
详情 |
详情
|
(VI) |
41650 |
(4S)-1-methyl-4-sulfanyl-2-pyrrolidinone
|
|
C5H9NOS |
详情 |
详情
|
(VII) |
37720 |
4-nitrobenzyl (4R,5R,6S)-6-[(1R)-1-hydroxyethyl]-4-methyl-3,7-dioxo-1-azabicyclo[3.2.0]heptane-2-carboxylate
|
|
C17H18N2O7 |
详情 |
详情
|
(VIII) |
13224 |
4-nitrobenzyl (4R,5R,6S)-3-[(diphenoxyphosphoryl)oxy]-6-[(1R)-1-hydroxyethyl]-4-methyl-7-oxo-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylate
|
90776-59-3 |
C29H27N2O10P |
详情 | 详情
|
(IX) |
41646 |
4-nitrobenzyl (4R,5S,6S)-6-[(1R)-1-hydroxyethyl]-4-methyl-3-[[(3S)-1-methyl-5-oxopyrrolidinyl]sulfanyl]-7-oxo-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylate
|
|
C22H25N3O7S |
详情 |
详情
|
(X) |
41647 |
sodium (4R,5S,6S)-6-[(1R)-1-hydroxyethyl]-4-methyl-3-[[(3S)-1-methyl-5-oxopyrrolidinyl]sulfanyl]-7-oxo-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylate
|
|
C15H19N2NaO5S |
详情 |
详情
|
(XI) |
11159 |
iodomethyl pivalate
|
|
C6H11IO2 |
详情 |
详情
|
合成路线22
该中间体在本合成路线中的序号:
(XIII) Oxocarbapenam (XII) was converted into vinyl phosphate (XIII) by treatment with diphenylphosphoryl chloride and diisopropylethylamine. Displacement of the phosphate group of (XIII) by 4-mercaptopyrrolidine-2-thione (IV) yielded carbapenem sulfide (XIV). After hydrogenolytic cleavage of the p-nitrobenzyl ester of (XIV) in the presence of Pd/C and KHCO3, the resulting potassium carboxylate salt (XV) was condensed with isobutyryloxymethyl iodide (XVI) to furnish the title compound.
【1】
Horikawa, H.; Iwasaki, T.; Kondo, K. (Tanabe Seiyaku Co., Ltd.); Process for preparing beta-lactam deriv. and synthetic intermediate thereof. EP 0559533 .
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(IV) |
37712 |
(4R)-4-sulfanyl-2-pyrrolidinethione
|
|
C4H7NS2 |
详情 |
详情
|
(XII) |
37720 |
4-nitrobenzyl (4R,5R,6S)-6-[(1R)-1-hydroxyethyl]-4-methyl-3,7-dioxo-1-azabicyclo[3.2.0]heptane-2-carboxylate
|
|
C17H18N2O7 |
详情 |
详情
|
(XIII) |
13224 |
4-nitrobenzyl (4R,5R,6S)-3-[(diphenoxyphosphoryl)oxy]-6-[(1R)-1-hydroxyethyl]-4-methyl-7-oxo-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylate
|
90776-59-3 |
C29H27N2O10P |
详情 | 详情
|
(XIV) |
37721 |
4-nitrobenzyl (4R,5S,6S)-6-[(1R)-1-hydroxyethyl]-4-methyl-7-oxo-3-[[(3R)-5-thioxopyrrolidinyl]sulfanyl]-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylate
|
|
C21H23N3O6S2 |
详情 |
详情
|
(XV) |
37722 |
potassium (4R,5S,6S)-6-[(1R)-1-hydroxyethyl]-4-methyl-7-oxo-3-[[(3R)-5-thioxopyrrolidinyl]sulfanyl]-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylate
|
|
C14H17KN2O4S2 |
详情 |
详情
|
(XVI) |
37723 |
iodomethyl 2-methylpropanoate
|
|
C5H9IO2 |
详情 |
详情
|
(XVII) |
37724 |
(isobutyryloxy)methyl (4R,5S,6S)-6-[(1R)-1-hydroxyethyl]-4-methyl-7-oxo-3-[[(3R)-5-thioxopyrrolidinyl]sulfanyl]-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylate
|
|
C19H26N2O6S2 |
详情 |
详情
|
合成路线23
该中间体在本合成路线中的序号:
(XV) Displacement of the mesylate group of (XII) with potassium thioacetate gave thioester (XIII), which was further hydrolyzed to thiol (XIV). This was condensed with enol phosphate (XV) to afford the protected 1-methylcarbapenem (XVI). Finally, deprotection of the p-nitrobenzyl groups of (XVI) by zinc powder in the presence of phosphate buffer (pH 6.0) provided the title compound.
【1】
Park, S.W.; Yoo, K.H.; Shin, K.J.; Kang, Y.K.; Hong, C.Y.; Seo, K.J.; Park, S.Y.; Lee, C.-S.; Kim, D.J.; Synthesis and antibacterial activity of new carbapenems containing isoxazole moiety. Bioorg Med Chem Lett 2000, 10, 2, 95.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(XII) |
44930 |
4-nitrobenzyl (2S,4R)-2-[(5R)-3-(hydroxymethyl)-4,5-dihydro-5-isoxazolyl]-4-[(methylsulfonyl)oxy]-1-pyrrolidinecarboxylate
|
|
C17H21N3O9S |
详情 |
详情
|
(XIII) |
44931 |
4-nitrobenzyl (2S,4S)-4-(acetylsulfanyl)-2-[(5R)-3-(hydroxymethyl)-4,5-dihydro-5-isoxazolyl]-1-pyrrolidinecarboxylate
|
|
C18H21N3O7S |
详情 |
详情
|
(XIV) |
44932 |
4-nitrobenzyl (2S,4S)-2-[(5R)-3-(hydroxymethyl)-4,5-dihydro-5-isoxazolyl]-4-sulfanyl-1-pyrrolidinecarboxylate
|
|
C16H19N3O6S |
详情 |
详情
|
(XV) |
13224 |
4-nitrobenzyl (4R,5R,6S)-3-[(diphenoxyphosphoryl)oxy]-6-[(1R)-1-hydroxyethyl]-4-methyl-7-oxo-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylate
|
90776-59-3 |
C29H27N2O10P |
详情 | 详情
|
(XVI) |
44933 |
4-nitrobenzyl (4R,5S,6S)-6-[(1R)-1-hydroxyethyl]-3-[((3S,5S)-5-[(5R)-3-(hydroxymethyl)-4,5-dihydro-5-isoxazolyl]-1-[[(4-nitrobenzyl)oxy]carbonyl]pyrrolidinyl)sulfanyl]-4-methyl-7-oxo-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylate
|
|
C33H35N5O12S |
详情 |
详情
|
合成路线24
该中间体在本合成路线中的序号:
(XIII) The reaction of the hydroxyproline 4-methoxybenzyl ester (VIII) with Ms-Cl and DIEA in THF gives the mesylate (IX), which is treated with thioacetic acid and Cs2CO3 in DMA to yield the acetylsulfanyl derivative (X). The Boc deprotection of (X) with 4N HCl in ethyl acetate, followed by methylation with HCHO/HCOOH and simultaneous ester hydrolysis, affords the methylated proline (XI), which is activated with pivaloyl chloride and DIEA in acetonitrile to the mixed anhydride (XII). The condensation of (XII) with the intermediate pyrrolidine (VII) by means of DIEA in acetonitrile provides the adduct (XIII), which is further condensed with the carbapenem (XIV) by means of NaOMe in methanol to give the intermediate (XV). Finally, this compound is deprotected by hydrogenation with H2 over Pd/C in THF/water to furnish the target 1-beta-methyl carbapenem.
【1】
Kanno, O.; Shibayama, T.; Ohya, S.; Shimoji, Y.; Kuwahara, S.; Ishikawa, K.; Kojima, K.; Kawamoto, I.; R-115685, a novel parenteral carbapenem: Synthesis and structure-activity relationships. 40th Intersci Conf Antimicrob Agents Chemother (Sept 17 2000, Toronto) 2000, Abst F-1229. |
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(VII) |
53608 |
2-({imino[(4-nitrobenzoyl)amino]methyl}amino)-N-[(3S)pyrrolidinyl]acetamide
|
n/a |
C14H18N6O4 |
详情 | 详情
|
(VIII) |
53609 |
1-(tert-butyl) 2-(4-methoxybenzyl) (2S,4R)-4-hydroxy-1,2-pyrrolidinedicarboxylate
|
n/a |
C18H25NO6 |
详情 | 详情
|
(IX) |
53610 |
1-(tert-butyl) 2-(4-methoxybenzyl) (2S,4R)-4-[(methylsulfonyl)oxy]-1,2-pyrrolidinedicarboxylate
|
n/a |
C19H27NO8S |
详情 | 详情
|
(X) |
53611 |
1-(tert-butyl) 2-(4-methoxybenzyl) (2S,4S)-4-(acetylsulfanyl)-1,2-pyrrolidinedicarboxylate
|
n/a |
C20H27NO6S |
详情 | 详情
|
(XI) |
53612 |
(2S,4S)-4-(acetylsulfanyl)-1-methyl-2-pyrrolidinecarboxylic acid
|
n/a |
C8H13NO3S |
详情 | 详情
|
(XII) |
53613 |
(2S,4S)-4-(acetylsulfanyl)-1-methyl-2-pyrrolidinecarboxylic 1,1-dimethylpropanoic anhydride
|
n/a |
C13H21NO4S |
详情 | 详情
|
(XIII) |
13224 |
4-nitrobenzyl (4R,5R,6S)-3-[(diphenoxyphosphoryl)oxy]-6-[(1R)-1-hydroxyethyl]-4-methyl-7-oxo-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylate
|
90776-59-3 |
C29H27N2O10P |
详情 | 详情
|
(XIV) |
53614 |
S-{(3S,5S)-5-[((3S)-3-{[2-({imino[(4-nitrobenzoyl)amino]methyl}amino)acetyl]amino}pyrrolidinyl)carbonyl]-1-methylpyrrolidinyl} ethanethioate
|
n/a |
C22H29N7O6S |
详情 | 详情
|
(XV) |
53615 |
4-nitrobenzyl (4R,5S,6S)-6-[(1R)-1-hydroxyethyl]-3-({(3S,5S)-5-[((3S)-3-{[2-({imino[(4-nitrobenzoyl)amino]methyl}amino)acetyl]amino}pyrrolidinyl)carbonyl]-1-methylpyrrolidinyl}sulfanyl)-4-methyl-7-oxo-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylate
|
n/a |
C37H43N9O11S |
详情 | 详情
|